Phase 2 Proof of concept clinical trial study designed to evaluate eDSP for the potential treatment of patients with Duchenne muscular dystrophy (DMD)

At a glance
Trial Overview
Trial Details
Interventions
Trial History
References

Trial Profile

Phase 2 Proof of concept clinical trial study designed to evaluate eDSP for the potential treatment of patients with Duchenne muscular dystrophy (DMD)

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 21 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary)
Indications Duchenne muscular dystrophy
Focus Proof of concept; Therapeutic Use

Most Recent Events

13 Aug 2024 According to Quince Therapeutics media release, the company is generating study designs and plans to initiate study in 2025, which the company expects to conduct utilizing capital efficient study approaches.
17 May 2024 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com